Skip to main content
. 2016 Sep 6;7(40):66100–66108. doi: 10.18632/oncotarget.11847

Table 4. Association between SP110 and PMP22 tSNP genotypes and TB risk.

SNP_ID Genotype No. (Frequency) OR 95%CI p value
Case Control
rs6436917 GG 61 (28.24%) 76 (19.84%) 1.72 1.08,2.74 0.021
GA 100 (46.30%) 189 (49.35%) 1.14 0.76,1.70 0.536
AA 55 (25.46%) 118 (30.81%) 1 -
rs4327230 GG 2 (0.92%) 12 (3.13%) 0.23 0.05,1.02 0.035
GC 30 (13.82%) 120 (31.33%) 0.34 0.21,0.53 <0.001*
CC 185 (85.25%) 251 (65.54%) 1 -
rs2114591 CC 10 (4.61%) 39 (10.18%) 0.35 0.17,0.730 0.004*
CT 68 (31.34%) 153 (39.95%) 0.61 0.43,0.88 0.007*
TT 139 (64.06%) 191 (49.87%) 1 -
rs7580912 CC 34 (15.67%) 54 (14.10%) 1.13 0.68,1.89 0.639
CT 105 (48.39%) 189 (49.35%) 1.00 0.69,1.44 0.988
TT 78 (35.94%) 140 (36.55%) 1 -
rs13422 AA 42 (19.35%) 45 (11.81%) 2.20 1.32,3.66 0.002*
AC 110 (50.69%) 183 (48.03%) 1.41 0.97,2.06 0.069
CC 65 (29.95%) 153 (40.16%) 1 -
rs230915 GG 13 (6.10%) 35 (9.26%) 0.62 0.32,1.22 0.165
GA 88 (41.31%) 156 (41.27%) 0.94 0.66,1.34 0.738
AA 112 (52.58%) 187 (49.47%) 1 -
rs231024 AA 16 (7.37%) 38 (9.92%) 0.63 0.34.191 0.154
AG 90 (41.47%) 178 (46.48%) 0.76 0.54,1.08 0.124
GG 111 (51.15%) 167 (43.60%) 1 -

OR: odd ratio; CI: confidence interval.

*p≤0.05.

Bonferroni's multiple adjustment was applied, with p<0.00178 (0.05/28).